New research indicates that individuals who discontinue new weight-loss injections like semaglutide or tirzepatide may regain reduced body mass much more quickly than those who stop traditional diet and exercise programs.
Findings released in a leading health publication shows that while overweight individuals frequently drop substantial amounts of their body weight while undergoing treatment, the weight is regained at an estimated rate of nearly a kilo each month once they quit.
"Users using these medications need to be cognizant of the risk of rapid rebound weight gain when the treatment concludes," warns researcher Dr. Susan Jebb.
That rate of recovery implies a reversion to starting mass within about 18 months.
Weighing Therapies
The analysis, which looked at dozens of studies involving thousands of participants, contrasted the outcomes of the injectable medications with other pills.
Scientists emphasize that people who shed pounds through lifestyle changes alone typically see a more gradual weight regain—around 0.1 kg a month—after stopping.
Understanding the Quick Rebound
Nutrition scientists suggest the mechanism of the jabs is key to understanding the accelerated rebound.
The injections imitate a natural hormone called GLP-1, which moderates feelings of fullness.
"Long-term administration of GLP-1 concentrations several times higher than the body's typical production could lead to the body to produce less of its own natural GLP-1, and may also diminish sensitivity to its actions," explained Dr. Adam Collins, a dietetics researcher.
"Withdrawal of this hormone supplement means appetite is unsuppressed, making overeating a significant risk."
A Lifelong Condition?
Health authorities recommend the jabs for people with weight-linked health risks, alongside prescribed lifestyle changes.
A number of clinicians contend that, given the high risk of relapse, the therapy is often life-long.
This opinion is supported by drug manufacturers, who state that the results "underscore the long-term character of obesity," akin to managing conditions like diabetes.
User Testimonies
Individuals who have come off the jabs explain a sudden return of appetite.
"It felt as if a trigger activating and I was suddenly extremely hungry," described a patient.
This challenge is worsened if users have not developed sustainable lifestyle or habit modifications during therapy.
Significant Adoption
Recent estimates show that millions of people in the UK have used these injections in the past year, with interest continuing to grow.
- Adoption is higher among females compared to men.
- The middle-aged demographic shows the highest usage rates.
- Many obtain the medications through private healthcare rather than the NHS.
In conclusion, researchers caution that while these medications are powerful tools for weight loss, they are not a standalone cure and maintained weight loss hinges on ongoing behavioural management.
